Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU5B-2P is a pseudogene annotated in the human genome. It shares sequence similarity with functional snRNAs of the U5 family, which are essential RNA components of the spliceosome responsible for pre-mRNA splicing. Unlike its functional paralogs (such as RNU5B-1), RNU5B-2P does not produce a stable or functional RNA product and is considered an inactive genomic sequence. There are no established molecular functions, disease associations, nor pharmacological interventions related to RNU5B-2P. Current research and disease roles focus on active snRNAs (such as RNU5B-1, RNU5A-1, or RNU4-2), which when mutated can cause neurodevelopmental disorders, but RNU5B-2P itself is not implicated in these processes[1][3][4]. If structured or actionable information is needed about spliceosomal snRNA drug targets or disease genes, refer to active genes in the U5 family (e.g., RNU5B-1).
None (no known mechanism of action for drugs, as it is not targeted)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5B small nuclear 2, pseudogene (RNU5B-2P).